New Study Links Coffee Consumption to Lower Liver Disease Risk

Your daily cup of coffee might actually help reduce your risk of liver disease or liver cancer, according to a significant new study. This holds true even if you’re one of those people who drink five or more cups a day.

Based on research involving over 354,000 participants tracked for over a decade, these findings were published in the journal Clinical Gastroenterology and Hepatology.

Dr. Hyunseok Kim, a hepatologist at Cedars-Sinai Medical Center in Los Angeles, stated, “This is probably the most comprehensive long-term follow-up data of coffee’s impact.” Interestingly, it appears that the benefits might not stem solely from caffeine, as similar positive effects were noted among those who consumed decaffeinated coffee. This suggests that the anti-oxidative properties of coffee could be key.

The researchers evaluated liver health by looking at cirrhosis cases, which involves serious liver damage and scarring from various long-term conditions, including fatty liver and viral hepatitis. Cirrhosis is a global concern, affecting more than 58 million people and leading to nearly 1.5 million deaths annually.

When it comes to hepatocellular carcinoma, the most common form of liver cancer, the statistics are dire, with about 685,000 cases and over 597,000 deaths each year worldwide.

The study revealed that drinking coffee might offer increased protection as consumption rises. For instance, one to two cups daily were linked to a 20% lower risk of cirrhosis, 24% lower risk of liver cancer, and 31% decreased odds of liver-related death. Moving up to three to four cups showed a 35% reduction risk for both cirrhosis and liver cancer, and a 41% lowered chance of liver-related death. Surprisingly, even drinking five cups or more was associated with a 32% decreased risk of cirrhosis, a 47% reduction in liver cancer risk, and a 42% lower chance of liver-related death.

Lauren Manaker, a registered dietitian who was not part of the study, commented that “those are meaningful numbers for something as ordinary as a daily cup of coffee.” However, she cautioned that these findings represent associations rather than direct causation.

The impact on those who sweetened their coffee, whether with sugar or substitutes, showed slightly lower risk reductions yet remained significant.

That said, it’s still wise to be mindful of your sugar and artificial sweetener intake. Participants using sweeteners showed increased markers for liver inflammation, which could potentially lead to fatty liver disease.

The American Heart Association advises keeping added sugars to no more than 6% of daily calories—about 9 teaspoons or 36 grams for men, and 6 teaspoons or 26 grams for women. On the caffeine side, the FDA recommends up to 400 milligrams per day for healthy adults, which equals roughly two to three 12-ounce cups of coffee. But, of course, everyone’s caffeine metabolism varies considerably.

To ensure caffeine doesn’t disrupt your sleep, it’s advisable to stop consuming it at least six hours before bed, with some experts recommending no caffeine after 3 p.m.

Advanced MRI imaging and various analyses in the study indicated that coffee drinkers also exhibited healthier liver protein profiles and reduced liver fat and inflammation.

Manaker pointed out that combining different types of evidence, like imaging and clinical outcomes, adds credibility to the overall results. “When the imaging and the proteins line up with the clinical outcomes, the overall picture becomes more believable.”

However, the study is not without limitations. Coffee consumption was only recorded at the study’s beginning and then assessed years later when MRIs were conducted. The time gap leaves room for other factors to come into play.

“We should treat that one early measurement as a rough guide to long-term habits rather than a precise record,” Manaker noted.

Moreover, over 90% of participants were European and comparatively health-conscious, and only a fraction underwent MRIs, which raises questions about the diversity and generalizability of the findings to broader populations.

Kim acknowledged potential biases, noting that the benefits observed might differ in more diverse ethnic groups like those in the US.

Still, he emphasized that the antioxidants in coffee might decrease the activation of pathways or proteins that lead to inflammation and scarring.

Interestingly, coffee may not just be a liver hero; other studies suggest it’s also associated with a lower risk of type 2 diabetes, heart disease, stroke, dementia, and an array of chronic diseases.